Status:
WITHDRAWN
RLIP76 in Human Serum in Adults With Rheumatologic Diseases
Lead Sponsor:
University of North Texas Health Science Center
Conditions:
Carotid Atherosclerosis
Eligibility:
All Genders
18+ years
Brief Summary
It is the investigators aim to determine the feasibility of directly detecting anti-RLIP76 auto-antibodies in human serum using prepared RLIP76 antigen peptides in persons with rheumatologic disease a...
Detailed Description
This is an exploratory study conducted to see the feasibility of measuring the anti-RLIP76 antibody and to standardize the methods for its measurement. We will perform these studies on blood samples o...
Eligibility Criteria
Inclusion
- Adult (age 18+), non-pregnant subjects with previously diagnosed rheumatologic disease will be candidates for the study.
Exclusion
- Children, pregnant women, prisoner, persons with any medical condition that precludes phlebotomy, and patients unwilling or unable to provide consent.
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2011
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00861159
Start Date
September 1 2011
End Date
September 1 2011
Last Update
January 12 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Texas Health Science Center
Fort Worth, Texas, United States, 76109